(2S)-3-[4-[3-(carboxymethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]oxyphenyl]-2-[(2-chlorobenzoyl)amino]propanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-3-[4-[3-(carboxymethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl]oxyphenyl]-2-[(2-chlorobenzoyl)amino]propanoic acid
• 化学式: C₃₀H₂₉ClN₂O₉
• 分子量: 597.0
• InChiKey: RMFJPQURTLXRSH-JWIMYKKASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  42
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  152
• 氢给体数：
  3
• 氢受体数：
  9

文献信息

• TYROSINE DERIVATIVES
  申请人：GENENTECH, INC.

  公开号：EP1214292B1

  公开（公告）日：2007-06-13
• Method for Augmenting B Cell Depletion
  申请人：Chan C. Andrew

  公开号：US20080075719A1

  公开（公告）日：2008-03-27

  The present invention provides methods of augmenting B cell depletion by promoting intravascular access of B cell subsets sequestered in lymphoid tissues rendering the B cells sensitive to killing mediated by the B cell depleting agent. One method of promoting intravascular access is by the use of integrin antagonists. Methods of treating B cell disorders by this approach is also provided.
• TYROSINE DERIVATIVE
  申请人：Jackson David Y.

  公开号：US20090325962A1

  公开（公告）日：2009-12-31

  The compounds of the invention are inhibitors of alpha4 containing integrin-mediated binding to ligands such as VCAM-1 and MAdCAM.
• US7595399B2
  申请人：——

  公开号：US7595399B2

  公开（公告）日：2009-09-29